rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2009-4-24
|
pubmed:abstractText |
There is limited information about optimal management of drug-eluting stent (DES) restenosis. This study evaluated the incidences of re-restenosis and re-target lesion revascularization (TLR) after the treatment of sirolimus-eluting stent (SES) restenosis.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1346-9843
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
73
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
867-71
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:19359815-Aged,
pubmed-meshheading:19359815-Angioplasty, Balloon, Coronary,
pubmed-meshheading:19359815-Cardiovascular Agents,
pubmed-meshheading:19359815-Coronary Restenosis,
pubmed-meshheading:19359815-Coronary Stenosis,
pubmed-meshheading:19359815-Drug-Eluting Stents,
pubmed-meshheading:19359815-Female,
pubmed-meshheading:19359815-Hospitals,
pubmed-meshheading:19359815-Humans,
pubmed-meshheading:19359815-Incidence,
pubmed-meshheading:19359815-Japan,
pubmed-meshheading:19359815-Logistic Models,
pubmed-meshheading:19359815-Male,
pubmed-meshheading:19359815-Middle Aged,
pubmed-meshheading:19359815-Prosthesis Design,
pubmed-meshheading:19359815-Retrospective Studies,
pubmed-meshheading:19359815-Risk Assessment,
pubmed-meshheading:19359815-Sirolimus,
pubmed-meshheading:19359815-Treatment Outcome
|
pubmed:year |
2009
|
pubmed:articleTitle |
Re-restenosis and target lesion revascularization after treatment of sirolimus-eluting stent restenosis: retrospective analysis of 4 Japanese hospitals.
|
pubmed:affiliation |
Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Japan.
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|